FDA Inspection 1095042 — Beth Israel Deaconess Medical Center
The FDA completed an inspection of Beth Israel Deaconess Medical Center on Jun 10, 2019 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 10, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Boston, MA (United States)